Presentation Information

[1SP-25-13 (1P-0517)]Structural development and inhibitory activity evaluation of isoliquiritigenin derivatives targeting aberrant activation of the CAPS-associated NLRP3-L353P mutant

○Miho Ito1, Reiji Ogawa1, Hiroe Honda2, Tadayoshi Karasawa3, Fumitake Usui-Kawanishi1, Masafumi Takahashi3, Yoshinori Nagai1 (1.Toyama Prefectural Univ., 2.Toyama Pref. Inst. Pharm. Res., 3.Div. Inflammation Res.,Ctr. Mol. Med., Jichi Med. Univ.)

Password required to view

Password required to view or download.
Check your name badge for the password.

Comment

To browse or post comments, you must log in.Log in